MONTANOVA CAPITAL, LLC — SEC Form 4 filings
SEC reporting owner CIK 1569064. 12 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-09-30 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 49 legs across 9 filings — 3,001,972 shares, $46,243,303 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 750,000 shares, $80,437,500 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 690,601 shares @ $107.25 ($74,066,957) in Veradermics, Inc, filed 2026-08-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Veradermics, Inc (MANE) | Director | 3 | 19 legs · 282,674 sh · $10,542,478 | 2 legs · 750,000 sh · $80,437,500 | 6 |
| Benitec Biopharma Inc. (BNTC) | Director, 10% owner | 9 | 30 legs · 2,719,298 sh · $35,700,825 | — | 10 |
Form 4 filings — MONTANOVA CAPITAL, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Veradermics, Inc (MANE) jointly with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | Sale (S): 690,601 @ $107.25 · Sale (S): 59,399 @ $107.25 · Option exercise/expiry (X): 149,000 · Option exercise/expiry (X): 151,000 · Option exercise/expiry (X): 149,000 (derivative) @ $0 · Option exercise/expiry (X): 151,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Veradermics, Inc (MANE) jointly with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | Grant/award (A): 149,000 (derivative) @ $100.00 · Grant/award (A): 151,000 (derivative) @ $100.00 | EDGAR |
| 2026-02-09 | 4 | Veradermics, Inc (MANE) jointly with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | Purchase (P): 10,004 @ $34.25 · Purchase (P): 10,676 @ $34.74 · Purchase (P): 14,659 @ $36.27 · Purchase (P): 53,344 @ $37.11 · Purchase (P): 25,908 @ $38.09 · Purchase (P): 18,489 @ $38.90 · +13 more | EDGAR |
| 2025-12-29 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | Purchase (P): 42,600 @ $12.85 · Purchase (P): 7,400 @ $12.85 · Purchase (P): 14,320 @ $13.10 · Purchase (P): 2,516 @ $13.10 · Purchase (P): 65,800 @ $13.44 · Purchase (P): 11,587 @ $13.44 | EDGAR |
| 2025-12-22 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | Purchase (P): 8,700 @ $11.24 · Purchase (P): 1,515 @ $11.24 · Purchase (P): 13,950 @ $11.48 · Purchase (P): 2,434 @ $11.48 · Purchase (P): 16,650 @ $12.08 · Purchase (P): 2,892 @ $12.08 | EDGAR |
| 2025-11-10 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Purchase (P): 730,370 @ $13.50 · Purchase (P): 751,111 @ $13.50 | EDGAR |
| 2025-04-02 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Purchase (P): 9,503 @ $12.63 · Purchase (P): 1,267 @ $12.63 · Purchase (P): 5,057 @ $13.22 · Purchase (P): 670 @ $13.22 | EDGAR |
| 2025-03-28 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Purchase (P): 793,800 @ $13 · Purchase (P): 106,200 @ $13 | EDGAR |
| 2024-12-26 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Purchase (P): 24,360 @ $10.98 · Purchase (P): 3,142 @ $10.98 · Purchase (P): 17,730 @ $11.25 · Purchase (P): 2,288 @ $11.25 | EDGAR |
| 2024-12-05 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Purchase (P): 37,190 @ $9.60 · Purchase (P): 4,810 @ $9.60 | EDGAR |
| 2024-11-21 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Purchase (P): 12,430 @ $9.73 · Purchase (P): 1,570 @ $9.73 · Purchase (P): 24,360 @ $10.22 · Purchase (P): 3,076 @ $10.22 | EDGAR |
| 2024-09-30 | 4 | Benitec Biopharma Inc. (BNTC) jointly with Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron | Option exercise/expiry (X): 588,236 @ $1.93 · Option exercise/expiry (X): 4,605,000 @ $3.86 · Option exercise/expiry (X): 1,219,970 @ $0.00 · Option exercise/expiry (X): 576,347 @ $3.86 · Option exercise/expiry (X): 148,210 @ $0.00 · Option exercise/expiry (X): 10,000,000 (derivative) @ $0 · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1569064 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →